Repare Therapeutics (PRTX) ($60MM market cap) is a clinical-stage oncology firm which by a collection of…
Category: Value Investing
Some hyperlinks 10/2025 | worth and alternative
After 60 years operating Berkshire, Warren Buffett introduced that he’ll retire by the top of the…
Fast updates: Robertet Annual outcomes, DCC Healthcare sale & Eurokai 2024 outcomes (together with some nerdy EPS changes)
Robertet After including Robertet to my “collector’s nook” a number of weeks in the past, Robertet…
Some hyperlinks 09/2025
The Bain Non-public Fairness Report and the corresponding materials is a should learn for anybody within…
Consultorio Bursátil – Abril 2025 (Worth Investing FM)
Consultorio bursátil de abril de 2025 en el que Adrián Godás y Paco Lodeiro respondemos a…
The 4 Ranges of Rationality: A Information for Buyers from Charlie Munger
For those who’ve been an investor lengthy sufficient, you’ve most likely heard somebody say, “Be rational.”…
Efficiency evaluate Q1 2025 – Remark: “Negotiation techniques & Achilles Heel”
Within the first 3 months of 2025, the Worth & Alternative portfolio gained +0,9% (together with…
Letter to A Younger Investor #10: The Most Essential Factor That Counts in Investing
A fast announcement earlier than I start right now’s submit – I’m internet hosting a brand new…
Clark Road Worth: Elevation Oncology: Damaged Biotech, Barely Riskier
Elevation Oncology (ELEV) (~$17MM market capitalization) is a clinical-stage biotech that till yesterday was pursuing the event…
The Honey Jar Dilemma: Of Companies, Excessive Margins, and Competitors
Over 30 million years in the past, the earth witnessed one of the crucial outstanding shifts…